Head-to-head · Value Score
CoreAge Rx vs Telos Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Telos Rx a 85. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameTelos Rx
#10 · Grade A- · Great Deal
Est. first month
$99/mo injectable
Save ~89% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 85 — an est. $99/mo first month, with no teaser step-up baked in. Telos Rx isn't out of it: Committed shoppers willing to lock in 6–12 months to unlock genuinely rock-bottom compounded pricing, who want oral or microdosed options on one platform.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Telos Rx |
|---|---|---|
| Value Score | 93 (A+) | 85 (A-) |
| Est. first month | $99/mo | $99/mo injectable |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $99/mo | $99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks |
| Tirzepatide | $149/mo | $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Not publicly listed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Telos Rx
Among the lowest published GLP-1 entry prices anywhere — microdosed semaglutide from $49/mo and tirzepatide from $99/mo — on a deep needle-free and oral menu, but the rock-bottom rates require a 6–12 month commitment, so the real month-to-month cost runs higher.
Why it's a deal
- Among the lowest published GLP-1 entry prices — microdosed sema from $49/mo and tirzepatide from $99/mo on annual plans
- Deep catalog including needle-free intranasal and oral/microdosed GLP-1 options
- LegitScript-certified and HIPAA-compliant, with HSA/FSA accepted and free 48-hour shipping
The fine print
- Rock-bottom prices require a 6–12 month commitment — real month-to-month cost is much higher ($145/$199/$399 first month)
- All compounded, not FDA-approved — and the research-grade peptides in its catalog have limited evidence
- Peptide and HRT pricing is hidden until you complete intake
- State list is not publicly published — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Telos Rx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.